Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Phase 2
Recruiting
- Conditions
- High Risk PregnancyPregnancy ComplicationsAntiphospholipid Syndrome in PregnancyLupus Anticoagulant Disorder
- Interventions
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- David Ware Branch
- Target Recruit Count
- 55
- Registration Number
- NCT03152058
- Locations
- 🇺🇸
Hospital for Special Surgery, New York, New York, United States
🇺🇸University of Utah, Salt Lake City, Utah, United States
🇨🇦TRIO Advancing Reproductive Care, Toronto, Ontario, Canada
News
No news found